Clostridium difficile isolated from the stool of a patient with pseudomembranous colits following ampicillin plus flucloxacillin (Magnapen) therapy.
A case is reported of the isolation of Clostridium difficile from the stool of a patient with antibiotic-related pseudomembranous colitis.
D000667:Ampicillin / Q000009:adverse effects*; D003013:Clostridium / Q000302:isolation & purification*; D003023:Cloxacillin / Q000031:analogs & derivatives*; D004338:Drug Combinations; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000382:microbiology*; D005243:Feces / Q000382:microbiology; D005260:Female; D005436:Floxacillin / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged
D004338:Drug Combinations; D005436:Floxacillin; D000667:Ampicillin; D003023:Cloxacillin